Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.
about
Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation.Inhibition of leucocyte motility by drugs used in ulcerative colitisImbalance of prostacyclin and thromboxane synthesis in Crohn's disease.Role of cyclooxygenase enzymes in a murine model of experimental cholera.Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.Drug therapy of inflammatory bowel disease.Prostaglandins and ulcerative colitis.Macrophage activation, chronic inflammation and gastrointestinal disease.Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease.Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: role of cytosolic free calcium.Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.Inhibition of prostaglandin synthetase in human rectal mucosa.Mechanism of action of 5-arninosalicylic acid.Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.Ulcerative colitis: an overview.Increased suppressor cell activity in inflammatory bowel disease.Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay.
P2860
Q34391539-560CC3A3-A8A3-4473-85BA-C7104409D94AQ34496132-F23F356F-474C-4B1C-BD0A-604CC3F70D56Q34496305-C0C6D104-8116-48FF-8217-7AEE2F4CAC41Q36375136-6BC12215-E539-4B37-B1B8-F1707F66FBE4Q36816563-0A69A04C-4AC8-4A7D-B807-F29CE6F7C66BQ39856402-C49CE506-3028-4252-99B5-2E86D7DB3093Q40090889-B4FF9F24-E703-4B28-B394-0AEDC97ADAADQ40096108-F4A19429-3B5C-4E5E-B573-8F10F3B37B2AQ40180168-A86C6486-0F6D-448D-8E42-3CD71BB140AFQ40845749-D54D069C-B5C4-438D-BCF7-910BBAA48EB3Q41222035-F23550A7-1BC0-49DA-875B-C9D6334F7809Q41830145-487259B7-F487-4134-8CB1-585A88AB3DBBQ41983408-F03F6D96-5D22-44F7-B794-C1F06EDF8DE5Q42106723-D8D83234-CB4F-4444-99B8-93E53A238D6AQ42136135-A269A367-B16E-4F6D-9016-1D1A4BF7F231Q43096294-E0FFDD31-F25E-4C66-98A7-5528B0C9EBF9Q43255584-46BB3D36-028F-40D2-8CF4-A57CF4B75DD3Q43255601-CD61E3CE-6409-437D-A9C2-A1D35AF005B2
P2860
Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Prostaglandin synthetase activ ...... ne phosphate and prednisolone.
@en
Prostaglandin synthetase activ ...... ne phosphate and prednisolone.
@nl
type
label
Prostaglandin synthetase activ ...... ne phosphate and prednisolone.
@en
Prostaglandin synthetase activ ...... ne phosphate and prednisolone.
@nl
prefLabel
Prostaglandin synthetase activ ...... ne phosphate and prednisolone.
@en
Prostaglandin synthetase activ ...... ne phosphate and prednisolone.
@nl
P2093
P2860
P356
P1433
P1476
Prostaglandin synthetase activ ...... ne phosphate and prednisolone.
@en
P2093
P2860
P304
P356
10.1136/GUT.20.9.802
P407
P577
1979-09-01T00:00:00Z